Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 409

1.

Carbenoxolone enhances peripheral insulin sensitivity and GLUT4 expression in skeletal muscle of obese rats: Potential participation of UBC9 protein.

Mori RC, Poças da Silva T, Campello RS, Machado UF.

Life Sci. 2019 Jul 15;229:157-165. doi: 10.1016/j.lfs.2019.05.017. Epub 2019 May 8.

PMID:
31077719
2.

Carbenoxolone ameliorates insulin sensitivity in obese mice induced by high fat diet via regulating the IκB-α/NF-κB pathway and NLRP3 inflammasome.

Chen Y, Qian Q, Yu J.

Biomed Pharmacother. 2019 Jul;115:108868. doi: 10.1016/j.biopha.2019.108868. Epub 2019 Apr 15.

3.

Carbenoxolone Could Deteriorate Streptozotocin-induced Diabetes through Induction of Heat Shock Protein 70 and IFN-γ in C57BL/6 Mice.

Rasouli M, Jafari-Khataylou Y, Ashrafi-Helan J.

Iran J Allergy Asthma Immunol. 2018 Dec 1;17(6):564-573.

4.

Analysis of carbenoxolone by ultra-high-performance liquid chromatography tandem mass spectrometry in mouse brain and blood after systemic administration.

Poklis JL, Gonek MM, Wolf CE, Akbarali HI, Dewey WL.

Biomed Chromatogr. 2019 Apr;33(4):e4465. doi: 10.1002/bmc.4465. Epub 2019 Jan 7.

PMID:
30548295
5.

Carbenoxolone-mediated cytotoxicity inhibits Vaccinia virus replication in a human keratinocyte cell line.

Haga IR, Simpson JL, Hawes PC, Beard PM.

Sci Rep. 2018 Nov 16;8(1):16956. doi: 10.1038/s41598-018-34732-w.

6.

Carbenoxolone Reverses the Amyloid Beta 1-42 Oligomer-Induced Oxidative Damage and Anxiety-Related Behavior in Rats.

Sharma S, Sharma N, Saini A, Nehru B.

Neurotox Res. 2019 Apr;35(3):654-667. doi: 10.1007/s12640-018-9975-2. Epub 2018 Nov 7.

PMID:
30402773
7.

Astrocytic gap junction inhibition by carbenoxolone enhances the protective effects of ischemic preconditioning following cerebral ischemia.

Ma D, Feng L, Cheng Y, Xin M, You J, Yin X, Hao Y, Cui L, Feng J.

J Neuroinflammation. 2018 Jul 5;15(1):198. doi: 10.1186/s12974-018-1230-5.

8.
9.

TAT-Gap19 and Carbenoxolone Alleviate Liver Fibrosis in Mice.

Crespo Yanguas S, da Silva TC, Pereira IVA, Willebrords J, Maes M, Sayuri Nogueira M, Alves de Castro I, Leclercq I, Romualdo GR, Barbisan LF, Leybaert L, Cogliati B, Vinken M.

Int J Mol Sci. 2018 Mar 12;19(3). pii: E817. doi: 10.3390/ijms19030817.

10.

Carbenoxolone as a novel therapy for attenuation of cancer-induced bone pain.

Falk S.

Pain. 2018 Jun;159(6):1127-1136. doi: 10.1097/j.pain.0000000000001197.

PMID:
29521811
11.

Carbenoxolone inhibits mechanical stress-induced osteogenic differentiation of mesenchymal stem cells by regulating p38 MAPK phosphorylation.

Li S, Wang J, Han Y, Li X, Liu C, Lv Z, Wang X, Tang X, Wang Z.

Exp Ther Med. 2018 Mar;15(3):2798-2803. doi: 10.3892/etm.2018.5757. Epub 2018 Jan 17.

12.

Quinine and carbenoxolone enhance the anticonvulsant activity of some classical antiepileptic drugs.

Franco-Pérez J, Manjarrez-Marmolejo J, Rodríguez-Balderas C, Castro N, Ballesteros-Zebadua P.

Neurol Res. 2018 Jan;40(1):26-33. doi: 10.1080/01616412.2017.1384092. Epub 2017 Oct 8.

PMID:
28988516
13.

Protective effects of carbenoxolone, an 11β-HSD1 inhibitor, against chemical induced dry eye syndrome.

Na YJ, Choi KJ, Park SB, Sung HR, Jung WH, Kim HY, Rhee SD, Kim KY.

Apoptosis. 2017 Nov;22(11):1441-1453. doi: 10.1007/s10495-017-1419-6.

PMID:
28887719
14.
15.

Carbenoxolone prevents chemical eye ischemia-reperfusion-induced cell death via 11β-hydroxysteroid dehydrogenase type 1 inhibition.

Choi KJ, Na YJ, Park SB, Jung WH, Sung HR, Kim KY.

Pharmacol Res. 2017 Sep;123:62-72. doi: 10.1016/j.phrs.2017.07.002. Epub 2017 Jul 4.

PMID:
28687341
16.

Inhibition of Alzheimer's amyloid-beta aggregation in-vitro by carbenoxolone: Insight into mechanism of action.

Sharma S, Nehru B, Saini A.

Neurochem Int. 2017 Sep;108:481-493. doi: 10.1016/j.neuint.2017.06.011. Epub 2017 Jun 24.

PMID:
28652220
17.

Carbenoxolone inhibits TRPV4 channel-initiated oxidative urothelial injury and ameliorates cyclophosphamide-induced bladder dysfunction.

Zhang X, Gao S, Tanaka M, Zhang Z, Huang Y, Mitsui T, Kamiyama M, Koizumi S, Fan J, Takeda M, Yao J.

J Cell Mol Med. 2017 Sep;21(9):1791-1802. doi: 10.1111/jcmm.13100. Epub 2017 Feb 28.

18.

Carbenoxolone Disodium Treatment for Canine Pituitary-Dependent Hyperadrenocorticism.

Teshima T, Matsumoto H, Okusa T, Uchiyama R, Koyama H.

PLoS One. 2016 Nov 8;11(11):e0166267. doi: 10.1371/journal.pone.0166267. eCollection 2016.

19.

Carbenoxolone exposure during late gestation in rats alters placental expressions of p53 and estrogen receptors.

Al-Bader MD, Jasem SA, Kilarkaje N.

Eur J Pharmacol. 2016 Nov 15;791:675-685. doi: 10.1016/j.ejphar.2016.09.035. Epub 2016 Sep 28.

PMID:
27693517
20.

A gap junction inhibitor, carbenoxolone, induces spatiotemporal dispersion of renal cortical perfusion and impairs autoregulation.

Mitrou N, Braam B, Cupples WA.

Am J Physiol Heart Circ Physiol. 2016 Sep 1;311(3):H582-91. doi: 10.1152/ajpheart.00941.2015. Epub 2016 Jul 1.

Supplemental Content

Loading ...
Support Center